[1]
Dutta, S. et al. 2021. Hydroxychloroquine as Therapeutic Option in COVID-19: Analysis of Suspected Cardiovascular Adverse Drug Events Reported in the VigiBase. Bangladesh Journal of Medical Science. 20, 4 (Jun. 2021), 897–910. DOI:https://doi.org/10.3329/bjms.v20i4.54150.